InterAx Biotech has started a new collaboration
Collaborations speed up innovation. InterAx Biotech AG, a spin-off of the Paul Scherrer Institute (PSI) and ETH Zurich, based at PARK INNOVAARE, and Professor...
More details More detailsWomen’s passion – the new frontier of innovation
Based on the “Appassionate” project – a book about women who transform their own passion into enterprises My work has always been to find stories...
More detailsEmerging applications of modular nanomaterials
When, back in 1999, the journal Nature published a letter about a material with a surface area of 2900 square meters in a single gram, many people believed...
More detailsGratXray sets up at PARK INNOVAARE to revolutionize breast cancer imaging
Recently founded, GratXray AG is developing a new technology for more precise breast cancer imaging. It will significantly reduce the number of false positives...
More detailsInterAx Biotech AG is strengthening its scientific advisory board
Scientific advisory boards set the bar for the quality of research and development performed in big pharma, medium biotech and small start-ups. Their excellence...
More detailsTeam PARK INNOVAARE: new contact person for industry representatives
Recently coming on board, Francesco Colonna has made PARK INNOVAARE’s team complete in his role as a Senior Project Manager Innovation and Funding. Francesco...
More detailsLife Science basic research on the top level
The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s...
More detailsA perfect site for biotech and pharma companies!
Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...
More detailsUp in the sky at THE TERRACE
Drones are one of the most buzzing vehicles today. You see them more and more often and when you don’t see them you might hear them flying nearby. It...
More detailsInfrastructure and R&D solutions for biotech and pharmaceutical industries
The Swiss Light Source (SLS) at the Paul Scherrer Institute (PSI) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability...
More detailsBiotech and pharma at PARK INNOVAARE
PARK INNOVAARE provides the best possible operating conditions for biotech and pharmaceutical companies. This includes the availability of modern laboratories...
More detailsCorporate Innovation Makeover: Excubation rules for the core business
This blog post is dedicated to the final three Excubation rules, and thus concludes our Corporate Innovation Makeover series. These three rules focus on...
More details